China’s biotechnology firm WuXi AppTec Co. has submitted an application for listing in Hong Kong, just months after it floated Shanghai initial public offering (IPO). The financial terms of the offering remains undisclosed. However, the offering could raise over US$1 billion, said Bloomberg citing people familiar with the matter. The company was listed in the New York Stock Exchange but was delisted in 2015 as its founder Li Ge and a group of investors including Hillhouse Capital and global healthcare-focused investment group Ally …

Chinese Biotech Firm WuXi AppTec Eyes $1B Hong Kong IPO appeared first on China Money Network.